Surrey

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• LEO Pharma3 trials

Running trials

• Recruiting

  A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

  NCT07013201· Phase 2· LEO Pharma· Source

  Contact: Clinical Disclosure

Closed trials

• Completed

  A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

  NCT05958407· Phase 3· LEO Pharma· Source

• Completed

  Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

  NCT03587805· Phase 3· LEO Pharma· Source